DI
NVO

DAGCO Inc’s Novo Nordisk NVO Stock Holding History

DAGCO Inc’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-450
Closed -$16.5K – 268
2026
Q1 		$16.5K Hold
450
– – ﹤0.01% 249
2025
Q4 		$22.9K Hold
450
– – 0.01% 243
2025
Q3 		$25K Hold
450
– – 0.01% 231
2025
Q2 		$31.1K Sell
450
-50
-10% -$3.4K 0.01% 208
2025
Q1 		$34.7K Buy
+500
New +$41.3K 0.01% 168
2024
Q4 		– Sell
-500
Closed -$59.5K – 156
2024
Q3 		$59.5K Hold
500
– – 0.02% 125
2024
Q2 		$71.4K Hold
500
– – 0.03% 109
2024
Q1 		$64.2K Buy
+500
New +$59.5K 0.03% 111

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

DAGCO Inc's NVO Position: Q2 2026 in Review

DAGCO Inc sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 450 shares — an estimated $16.5K sold.

DAGCO Inc first reported a position in NVO in Q1 2024 and held it in 8 quarters. The position peaked at $71.4K in Q2 2024. 387 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • DAGCO Inc reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • DAGCO Inc sold 450 Novo Nordisk shares in Q2 2026, an estimated $16.5K.
  • DAGCO Inc first reported a position in Novo Nordisk in Q1 2024 and held it in 8 quarters.
  • DAGCO Inc's Novo Nordisk position peaked at $71.4K in Q2 2024.
  • 387 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on DAGCO Inc's 13F filing for Q2 2026, filed 10 Jul 2026.